4//SEC Filing
Kelly Timothy P 4
Accession 0000899243-21-004998
CIK 0001661998other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:31 AM ET
Size
8.7 KB
Accession
0000899243-21-004998
Insider Transaction Report
Form 4
Kelly Timothy P
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2021-02-02$6.63/sh+500$3,316→ 500 total - Sale
Common Stock
2021-02-02$13.00/sh−500$6,500→ 0 total - Exercise/Conversion
Employee Stock Options
2021-02-02−500→ 44,500 totalExercise: $6.63Exp: 2027-12-06→ Common Stock (500 underlying)
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020.
- [F2]The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018, so that such option will become fully vested on January 1, 2022.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001754067
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 6:31 AM ET
- Size
- 8.7 KB